PubMed · 8684952
The source did not provide an abstract. Follow the original record for more information.
Explore connections, maps & timelines
C Gibbon, K Kendrick. Education. Practical conflicts.. https://pubmed.ncbi.nlm.nih.gov/8684952/
Cite the original work for its findings. Save a collection to share your selection of sources.
KEEP EXPLORING
As with all subspecialties, the endocrine surgeon offers more than just improved technical expertise in the treatment of endocrine surgical disease. An understanding of the disease, and an ability to interpret investigations and surgically intervene with minimal morbidity allow for better patient care. Outcomes of endocrine surgical diseases are measured by the success of the operation at relieving the endocrinopathy and the ability of the surgeon to find the tumor, while at the same time minimizing the postoperative morbidity. Each of these factors has been considered when assessing the role of specialized expertise in endocrine surgical disease. The recurrence and survival data for these tumors, however, are not forthcoming and, therefore, the limitations of the existing literature must be acknowledged.
The outcome following surgery for resection of a solid tumor depends on a number of factors including patient comorbidity, stage of the disease, and surgical expertise. Each of these aspects must be considered when outcome data are being assessed. This multifactorial concept makes the relative importance of volume and specialization difficult to assess for individual patients. This article investigates the role of volume and specialization in determining outcome following solid tumor resection.
Surgery is the only possible curative treatment for gastric cancer. Although outcomes over the years have improved, there are still many controversies in the treatment of gastric cancer. One highly controversial topic is the extent of the operation. Results of recently performed large randomized studies may cause some policies to change. This article addresses the influence of surgery on outcomes of D1-D2 dissections, total versus subtotal gastrectomy, and pancreas and spleen resection and staging. Furthermore, several aspects of patient selection, the surgeon as a prognostic factor, noncurative treatment, and chemotherapy are discussed.